Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...

Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people with PAH.

The FDA is poised to issue a final decision on the approval and marketing of Yutrepia, an inhaled dry powder formulation of ...

Pulmonary hypertension is linked to an increased risk for sleep apnea and structural brain changes at the genetic level, a ...

Tech improvements have benefited the chronic illness community, writes columnist Anna Jeter, who shares things she uses to manage her health.